Ectopic fat accumulation and metabolic syndrome
Neda Rasouli1, Behzad Molavi, Steven C Elbein
1The Central Arkansas Veterans Healthcare System, Little Rock, AR, USA. rasoulineda@uams.edu
Diabetes, Obesity & Metabolism
|January 4, 2007
Summary
Metabolic syndrome, a cluster of conditions including obesity and hypertension, is a growing public health concern linked to diabetes and cardiovascular disease. This review explores the role of ectopic fat in its development.
Area of Science:
- Endocrinology
- Public Health
- Cardiovascular Medicine
Background:
- Obesity has escalated to epidemic proportions, highlighting metabolic syndrome as a major public health issue.
- Metabolic syndrome, characterized by abdominal obesity, hypertension, and dyslipidemia, is a significant risk factor for diabetes and cardiovascular disease.
- The precise pathological mechanisms underlying metabolic syndrome remain incompletely understood.
Purpose of the Study:
- To review current literature on the pathogenesis of metabolic syndrome.
- To emphasize the role of ectopic lipid accumulation in the development of metabolic syndrome.
Main Methods:
- Literature review of current research on metabolic syndrome.
- Focus on studies investigating the role of ectopic fat deposition.
Main Results:
- Ectopic lipid accumulation is increasingly recognized as a key factor in metabolic syndrome development.
- Understanding these mechanisms is crucial for preventing associated cardiovascular complications.
Conclusions:
- Further research into the role of ectopic fat is essential for elucidating metabolic syndrome pathogenesis.
- Identifying the exact pathophysiological events may lead to targeted interventions for this widespread condition.
Related Concept Videos
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:24Overview of Lipid Metabolism
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...